Barclays’s AC Immune ACIU Stock Holding History
Bought
Maintained
Sold
Other funds holding ACIU
Barclays's ACIU Position: Q3 2026 in Review
Barclays increased its AC Immune (ACIU) stake by 27% in Q3 2026, buying an estimated $5K and bringing the position to 9,246 shares worth $24.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4719.
Barclays first reported a position in ACIU in Q4 2017 and has held it in 22 quarters since. The position peaked at $131K in Q4 2017. 27 funds tracked by Wall St. Rank hold ACIU as of Q3 2026.
- Barclays held 9,246 shares of AC Immune worth $24.2K as of Q3 2026.
- Barclays bought 1,968 AC Immune shares in Q3 2026, an estimated $5K.
- AC Immune made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #4719 holding.
- Barclays first reported a position in AC Immune in Q4 2017 and has held it in 22 quarters since.
- Barclays's AC Immune position peaked at $131K in Q4 2017.
- 27 funds tracked by Wall St. Rank held AC Immune as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.